These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4119747)

  • 1. Sustained-release levodopa in parkinsonism.
    Eckstein B; Shaw K; Stern G
    Lancet; 1973 Feb; 1(7800):431-2. PubMed ID: 4119747
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
    Reid JL; Calne DB; Vakil SD; Allen JG; Davies CA
    J Neurol Sci; 1972 Sep; 17(1):45-51. PubMed ID: 4560435
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-lasting dyskinesia induced by levodopa.
    Weiss JL; Ng LK; Chase TN
    Lancet; 1971 May; 1(7707):1016-7. PubMed ID: 4102427
    [No Abstract]   [Full Text] [Related]  

  • 6. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis.
    Chase TN; Holden EM; Brody JA
    Arch Neurol; 1973 Nov; 29(5):328-33. PubMed ID: 4743883
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.
    Godwin-Austen RB; Bergmann S; Frears CC
    Br Med J; 1971 Nov; 4(5786):522-4. PubMed ID: 4942463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release levodopa in Parkinsonism.
    Curzon G; Friedel J; Grier L; Marsden CD; Parkes JD; Shipley M; Zilkha KJ
    Lancet; 1973 Apr; 1(7806):781. PubMed ID: 4120768
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained levodopa therapy in parkinsonism.
    Hunter KR; Shaw KM; Laurence DR; Stern GM
    Lancet; 1973 Oct; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract]   [Full Text] [Related]  

  • 12. The choreoathetoid movement disorder induced by levodopa.
    Markham CH
    Clin Pharmacol Ther; 1971; 12(2):340-3. PubMed ID: 5577482
    [No Abstract]   [Full Text] [Related]  

  • 13. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.
    Klawans HL; Weiner WJ
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):427-30. PubMed ID: 4838914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of parkinsonism with levodopa.
    Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
    Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa in Parkinsonism.
    Weiss JL; Chase TN
    Drugs; 1971; 2(4):257-61. PubMed ID: 4948349
    [No Abstract]   [Full Text] [Related]  

  • 16. Levodopa and adventitious movements.
    Lieberman AN; Pedersen B
    Lancet; 1970 Nov; 2(7680):985. PubMed ID: 4097634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW; Deze J; Gundlach U; Muschard F
    Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994
    [No Abstract]   [Full Text] [Related]  

  • 18. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of parkinsonism with levodopa.
    Sutcliffe RL
    Gerontol Clin (Basel); 1974; 16(1):151-6. PubMed ID: 4855131
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Parkinsonism with Laevo-dopa.
    Mawdsley C
    Br Med J; 1970 Feb; 1(5692):331-7. PubMed ID: 4906702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.